BIOLASE. INC

BIOLASE, INC. specializes in the design, development, and manufacturing of advanced medical laser systems for clinical applications, primarily serving dental and surgical markets. As a Class II medical device manufacturer under NAICS 339114, the company leverages proprietary diode and erbium laser technologies to deliver precision-driven solutions for soft and hard tissue procedures. Their technical expertise includes photobiomodulation, minimally invasive surgical platforms, and FDA-cleared laser delivery systems optimized for clinical safety and reproducibility. Key differentiators include integrated thermal management, real-time tissue response feedback, and compact, user-centric device architectures tailored for outpatient and hospital-based settings. The company’s engineering focus centers on regulatory-compliant product lifecycle management, biocompatible material selection, and ISO 13485-aligned quality systems. Award history is not available to infer specific agency engagements or procurement patterns. Consequently, no definitive agency relationships or mission-specific program contributions can be identified from the provided data. The company operates within the medical device manufacturing vertical, with primary focus on laser-based diagnostic and therapeutic equipment. Their market positioning is centered on innovation in clinical laser technology, serving healthcare providers through FDA-regulated Class II devices that require rigorous design controls and post-market surveillance. BIOLASE is not certified under any federal small business or socio-economic programs, and its geographic footprint is anchored in Foothill Ranch, California, where its R&D and manufacturing operations are consolidated. The organization maintains a niche presence in the government healthcare supply chain through direct procurement channels, though no public contract data confirms active federal program participation.